Endothelial dysfunction in COVID-19 induces a prothrombotic endothelial state, characterized by increased expression of tissue factor, von Willebrand factor, and impaired thrombomodulin and antithrombin activity, promoting coagulation activation and thrombus formation37. The gene discussed is THBD; the disease is endothelial dysfunction.